About 3-[3-[(1,1-dihydroxy-4-methyl-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-5-(1-ethylimidazol-4-yl)pentanoic acid
3-[3-[(1,1-dihydroxy-4-methyl-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-5-(1-ethylimidazol-4-yl)pentanoic acid (PubChem CID 122653309) has the molecular formula C27H35N3O5S
and a molecular weight of 513.66 g/mol. Its IUPAC name is 3-[3-[(1,1-dihydroxy-4-methyl-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-5-(1-ethylimidazol-4-yl)pentanoic acid.
Analyze 3-[3-[(1,1-dihydroxy-4-methyl-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-5-(1-ethylimidazol-4-yl)pentanoic acid with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 3-[3-[(1,1-dihydroxy-4-methyl-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-5-(1-ethylimidazol-4-yl)pentanoic acid?
The IUPAC name of 3-[3-[(1,1-dihydroxy-4-methyl-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-5-(1-ethylimidazol-4-yl)pentanoic acid (CID 122653309) is 3-[3-[(1,1-dihydroxy-4-methyl-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-5-(1-ethylimidazol-4-yl)pentanoic acid.
What is the SMILES notation for 3-[3-[(1,1-dihydroxy-4-methyl-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-5-(1-ethylimidazol-4-yl)pentanoic acid?
The canonical SMILES for 3-[3-[(1,1-dihydroxy-4-methyl-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-5-(1-ethylimidazol-4-yl)pentanoic acid is CCn1cnc(CCC(CC(=O)O)c2ccc(C)c(CN3CC(C)Oc4ccccc4S3(O)O)c2)c1.
What is the InChIKey of 3-[3-[(1,1-dihydroxy-4-methyl-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-5-(1-ethylimidazol-4-yl)pentanoic acid?
The InChIKey is RBSCEDGZFWZSNZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H35N3O5S/c1-4-29-17-24(28-18-29)12-11-22(14-27(31)32)21-10-9-19(2)23(13-21)16-30-15-20(3)35-25-7-5-6-8-26(25)36(30,33)34/h5-10,13,17-18,20,22,33-34H,4,11-12,14-16H2,1-3H3,(H,31,32).
What are the key properties of 3-[3-[(1,1-dihydroxy-4-methyl-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-5-(1-ethylimidazol-4-yl)pentanoic acid?
3-[3-[(1,1-dihydroxy-4-methyl-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-5-(1-ethylimidazol-4-yl)pentanoic acid has a molecular weight of 513.66 g/mol, XLogP of 5.71, 9 rotatable bonds, 3 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[3-[(1,1-dihydroxy-4-methyl-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-5-(1-ethylimidazol-4-yl)pentanoic acid is sourced from PubChem (CID 122653309), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).